Skip to content
AiONAiON
Medical directoryActive ingredient

Falsified semaglutide

Falsified Ozempic pens found in circulation in Europe, about which the AEMPS issued multiple alerts in 2023 and 2024. Their adulterated content has caused serious harm to patients, including cases of severe hypoglycaemia.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.